Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Eye Bacteria Changes With Contact Lenses

Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections, a new study suggests.

MPR Celebrates Its 30th Anniversary

Ophthalmic NSAIDs for Common Indications Compared

A recent review compared published data on the efficacy of several ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), within and outside their FDA-approved uses.

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Ocular Syphilis: What Clinicians Should Know

The Centers for Disease Control and Prevention (CDC) has issued a clinical advisory on ocular syphilis due to recent confirmed and suspected cases in several states.

Eye Complications Possible with Measles

In the midst of the current resurgence of measles across the United States, ophthalmologists are warning that even before the telltale skin rash appears, the infection typically shows up in the eyes.

FDA Expands Eylea Indication

The Food and Drug Administration (FDA) has granted expanded the use of Eylea (aflibercept; Regeneron) injection to treat diabetic retinopathy in patients with diabetic macular edema (DME).

Binocular Vision Linked to Increased Injuries

For older Medicare beneficiaries, having a disorder of binocular vision is associated with increased odds of musculoskeletal injury, fracture, and fall.

News

Device Helps Blind Patients Process Visual Images with Their Tongues

The FDA has approved for marketing the BrainPort V100 (Wicab, Inc.) device to help orient blind people by helping them process visual images with their tongues, when used with other assistive devices (eg, cane, guide dog).

Black Box Warning for Potiga Reviewed Again by FDA

The Food and Drug Administration (FDA) has determined that the Boxed Warning for Potiga (ezogabine; GlaxoSmithKline) is adequate to manage the potential risks of vision loss due to pigment changes in the retina and skin discoloration.

UWF Retinal Imaging Process Could Reduce Practice Burden

Real-time ultrawide field retinal imaging has high sensitivity, specificity for detecting referable DR

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Cannabinoid Offers Modest Relief From Pain, SpasticityExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Blurred vision - Red flag symptomsExternal web site

Blurred vision - Red flag symptoms

0.50 Credits

Pulmonology, Pediatrics, Ophthalmology, and ENTExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...

CME 4.50 Credits

Sign Up for Free e-newsletters